SCHEMBL24399172

SCHEMBL24399172

BC1(B)C(B)(O)C(B)(O)C2(Cn3cc(-c4ncnc5[nH]ccc45)cn3)OC12O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 19/20 0.50
HDAC6 Q9UBN7 12/20 0.50
HDAC1 Q13547 9/20 0.49
JAK1 P23458 9/20 0.48
JAK3 P52333 5/20 0.48
TYK2 P29597 4/20 0.48
HDAC3 O15379 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC10 Q969S8 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
HDAC5 Q9UQL6 2/20 0.48
NCOR2 Q9Y618 2/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
CIT O14578 2/20 0.40
GAK O14976 2/20 0.40
ROCK2 O75116 2/20 0.40
ULK1 O75385 2/20 0.40
RET P07949 2/20 0.40
PRKCA P17252 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27435175 0.86 JAK2 (0.50) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL27435340 0.85 JAK2 (0.52) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL24399312 0.81 JAK2 (0.50) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL24053067 0.80 JAK2 (0.55) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL24399289 0.76 JAK2 (0.51) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL19578571 0.74 JAK2 (0.53) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL13774665 0.73 JAK2 (0.61) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL28340692 0.73 JAK2 (0.61) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL27315799 0.72 JAK2 (0.53) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL13695723 0.71 JAK2 (0.65) JAK2HDAC6HDAC1JAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022094133-A9 REGIMENS FOR THE TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS SUN PHARMACEUTICAL INDUSTRIES, INC. (US) 2023-05-19 WO disclosed
WO-2022094133-A1 REGIMENS FOR THE TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS CONCERT PHARMACEUTICALS, INC. (US) 2022-05-05 WO disclosed